BR9913357A - Formas cristalinas do osanetante - Google Patents
Formas cristalinas do osanetanteInfo
- Publication number
- BR9913357A BR9913357A BR9913357-1A BR9913357A BR9913357A BR 9913357 A BR9913357 A BR 9913357A BR 9913357 A BR9913357 A BR 9913357A BR 9913357 A BR9913357 A BR 9913357A
- Authority
- BR
- Brazil
- Prior art keywords
- crystalline forms
- osanetante
- osanetant
- piperidin
- methylacetamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Patente de Invenção: <B>"FORMAS CRISTALINAS DO OSANETANTE"<D>. A presente invenção refere-se a um processo para a preparação das formas cristalinas I e II do (R)-(+)-N[[3-[1-benzoil-3-(3,4-diclorofenil)piperidin-3-il]prop-1-il]-4-fenil piperidin-4-il]-N-metilacetamida (osanetante), assim como às ditas formas cristalinas I e II do osanetante. Preferencialmente, o osanetante a cristalizar é preparado a partir de seu benzenossulfonato.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9810107A FR2782082B3 (fr) | 1998-08-05 | 1998-08-05 | Formes cristallines de (r)-(+)-n-[[3-[1-benzoyl-3-(3,4- dichlorophenyl)piperidin-3-yl]prop-1-yl]-4-phenylpiperidin-4 -yl]-n-methylacetamide (osanetant) et procede pour la preparation dudit compose |
PCT/FR1999/001914 WO2000007987A1 (fr) | 1998-08-05 | 1999-08-03 | Formes cristallines du osanetant |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9913357A true BR9913357A (pt) | 2001-05-15 |
Family
ID=9529458
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9913357-1A BR9913357A (pt) | 1998-08-05 | 1999-08-03 | Formas cristalinas do osanetante |
Country Status (32)
Country | Link |
---|---|
US (1) | US7041679B2 (pt) |
EP (1) | EP1102747B1 (pt) |
JP (1) | JP3807938B2 (pt) |
KR (1) | KR100571944B1 (pt) |
CN (1) | CN1114592C (pt) |
AR (1) | AR019953A1 (pt) |
AT (1) | ATE243197T1 (pt) |
AU (1) | AU748177B2 (pt) |
BR (1) | BR9913357A (pt) |
CA (1) | CA2339007A1 (pt) |
CO (1) | CO5070576A1 (pt) |
DE (1) | DE69908951T2 (pt) |
DK (1) | DK1102747T3 (pt) |
DZ (1) | DZ3074A1 (pt) |
EA (1) | EA003205B1 (pt) |
EE (1) | EE04274B1 (pt) |
ES (1) | ES2200535T3 (pt) |
FR (1) | FR2782082B3 (pt) |
HK (1) | HK1035535A1 (pt) |
HU (1) | HUP0103134A3 (pt) |
IS (1) | IS5821A (pt) |
MY (1) | MY121447A (pt) |
NO (1) | NO320645B1 (pt) |
NZ (1) | NZ509561A (pt) |
PL (1) | PL345999A1 (pt) |
PT (1) | PT1102747E (pt) |
SK (1) | SK1742001A3 (pt) |
TR (1) | TR200100261T2 (pt) |
TW (1) | TW527354B (pt) |
UA (1) | UA72890C2 (pt) |
WO (1) | WO2000007987A1 (pt) |
YU (1) | YU8601A (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0100902D0 (sv) | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0202539D0 (sv) | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
SE0401762D0 (sv) * | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Novel compounds |
US7648992B2 (en) * | 2004-07-05 | 2010-01-19 | Astrazeneca Ab | Hydantoin derivatives for the treatment of obstructive airway diseases |
SE0403086D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Compounds |
SE0403085D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Novel componds |
TW200800954A (en) * | 2006-03-16 | 2008-01-01 | Astrazeneca Ab | Novel crystal modifications |
TW200831488A (en) * | 2006-11-29 | 2008-08-01 | Astrazeneca Ab | Novel compounds |
TW202317533A (zh) * | 2021-07-02 | 2023-05-01 | 美商雅斯治療公司 | 奧沙奈坦(osanetant)之固體形式 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2719311B1 (fr) * | 1994-03-18 | 1998-06-26 | Sanofi Sa | Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic. |
JPH1053576A (ja) * | 1996-06-07 | 1998-02-24 | Eisai Co Ltd | 塩酸ドネペジルの多形結晶およびその製造法 |
EP0915849A2 (en) * | 1996-08-05 | 1999-05-19 | Smithkline Beecham S.p.A. | Process for the preparation of 3,3-disubstituted piperidines |
US6040316A (en) * | 1996-09-16 | 2000-03-21 | Warner-Lambert Company | 3-alkyl-3-phenyl-piperidines |
FR2757543B1 (fr) * | 1996-12-23 | 1999-04-02 | Sanofi Sa | Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues |
-
1998
- 1998-08-05 FR FR9810107A patent/FR2782082B3/fr not_active Expired - Lifetime
-
1999
- 1999-07-25 DZ DZ990156A patent/DZ3074A1/xx active
- 1999-07-28 AR ARP990103741A patent/AR019953A1/es unknown
- 1999-08-03 DE DE69908951T patent/DE69908951T2/de not_active Expired - Fee Related
- 1999-08-03 ES ES99936672T patent/ES2200535T3/es not_active Expired - Lifetime
- 1999-08-03 WO PCT/FR1999/001914 patent/WO2000007987A1/fr not_active Application Discontinuation
- 1999-08-03 DK DK99936672T patent/DK1102747T3/da active
- 1999-08-03 UA UA2001010591A patent/UA72890C2/xx unknown
- 1999-08-03 YU YU8601A patent/YU8601A/sh unknown
- 1999-08-03 AT AT99936672T patent/ATE243197T1/de not_active IP Right Cessation
- 1999-08-03 KR KR1020017001460A patent/KR100571944B1/ko not_active IP Right Cessation
- 1999-08-03 JP JP2000563621A patent/JP3807938B2/ja not_active Expired - Fee Related
- 1999-08-03 AU AU51685/99A patent/AU748177B2/en not_active Ceased
- 1999-08-03 CN CN99810182A patent/CN1114592C/zh not_active Expired - Fee Related
- 1999-08-03 SK SK174-2001A patent/SK1742001A3/sk unknown
- 1999-08-03 EP EP99936672A patent/EP1102747B1/fr not_active Expired - Lifetime
- 1999-08-03 EE EEP200100070A patent/EE04274B1/xx not_active IP Right Cessation
- 1999-08-03 PT PT99936672T patent/PT1102747E/pt unknown
- 1999-08-03 NZ NZ509561A patent/NZ509561A/xx unknown
- 1999-08-03 EA EA200100096A patent/EA003205B1/ru not_active IP Right Cessation
- 1999-08-03 MY MYPI99003297A patent/MY121447A/en unknown
- 1999-08-03 PL PL99345999A patent/PL345999A1/xx not_active Application Discontinuation
- 1999-08-03 CA CA002339007A patent/CA2339007A1/en not_active Abandoned
- 1999-08-03 TR TR2001/00261T patent/TR200100261T2/xx unknown
- 1999-08-03 HU HU0103134A patent/HUP0103134A3/hu unknown
- 1999-08-03 BR BR9913357-1A patent/BR9913357A/pt not_active IP Right Cessation
- 1999-08-04 CO CO99049286A patent/CO5070576A1/es unknown
- 1999-08-04 TW TW088113235A patent/TW527354B/zh not_active IP Right Cessation
-
2001
- 2001-01-23 IS IS5821A patent/IS5821A/is unknown
- 2001-02-01 NO NO20010553A patent/NO320645B1/no unknown
- 2001-09-04 HK HK01106232A patent/HK1035535A1/xx not_active IP Right Cessation
-
2003
- 2003-08-28 US US10/651,313 patent/US7041679B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9913357A (pt) | Formas cristalinas do osanetante | |
RU2358979C2 (ru) | Модифицированные фторированные аналоги нуклеозида | |
PT788481E (pt) | Processo para preparacao de levobupivacaina e seus analogos | |
BR0016150A (pt) | Compostos, composições e métodos para estìmulo de crescimento e alongamento neuronal | |
DE69904302D1 (de) | Farnesyltransferase-inhibitoren mit piperidinstruktur und verfahren zu ihrer herstellung | |
PT1082293E (pt) | Polimorfos de formoterol | |
BR9608288A (pt) | Processo para preparar ésteres de ácido trópico enanciomericamente puros | |
BR0008440A (pt) | Inibidor de metaloprotease de sulfamato do ácido hidroxâmico | |
BR0109109A (pt) | Composto, uso do mesmo, processo para prepará-lo, composição farmacêutica, e, método de tratar um estado doentio mediado por ccr5 em mamìferos | |
BR0011622A (pt) | Composto, processo para a preparação de composições aquosas de ácido percarboxìlico, composição aquosa de ácido percarboxìlico, e, uso de uma composição | |
BR0308110A (pt) | Preparação de aluminossilicato zeolìtico cristalino do tipo mfi | |
RU2003137600A (ru) | Крем для лечения солнечных ожогов | |
IT1319234B1 (it) | Processo di preparazione di gabapentina. | |
BR0014149A (pt) | Componentes de formulação resistentes à decomposição por aromatização, composições e métodos de lavagem empregando os mesmos | |
BR9803949A (pt) | Cristais de maltitol de formas particulares, composições cristalinas contendo os mesmos e processo para fabriacação dos mesmos | |
BR0008776A (pt) | Análogos de prostaglandinas fp-seletivosinsaturados c16 | |
BR9903282A (pt) | Compostos de nitrona, um processo para a preparação dos mesmos e composições farmacêuticas que contêm os mesmos | |
BR0111427A (pt) | Modificação de cristal | |
BR9805708A (pt) | Escova de dentes e processo para fazê-la | |
RU2009131039A (ru) | Композиция для распрямления волос | |
HU226362B1 (en) | Brush for improved tuft retention and anchor wire therefor | |
BR0317665A (pt) | 1-alquil-3-aminoindazóis | |
BR9910085A (pt) | Processo para a cristalização de um antibiótico de beta-lactama | |
ATE407933T1 (de) | Verfahren zur herstellung von paroxetin hydrochlorid hemihydrat | |
NO308841B1 (no) | FremgangsmÕte ved krystallisasjon av (S)-N,N'-bis[2-hydroksy- 1-(hydroksymetyl)etyl]-5[(2-hydroksy-1-oksopropyl)amino]-2,4,6- trijod-1,3-benzendikarboksamid fra vann, samt anvendelser av (C1- C4-alkoholer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1942 DE 25/03/2008. |